Testosterone/SEPA - Access Pharmaceuticals

Alternative Names: Opterone™; SEPA-enhanced testosterone; Testosterone-topical - Access Pharmaceuticals

Latest Information Update: 04 Mar 2009

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator MacroChem
Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
Mechanism of Action Testosterone agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Hypogonadism

Most Recent Events

23 Jan 2015 Biomarkers information updated
26 Feb 2009 MacroChem has been acquired and integrated into Access Pharmaceuticals
12 Sep 2005 Discontinued - Phase-I for Hypogonadism in USA (Topical)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.